A TEST to detect Human Papillomavirus (HPV) on the cervix has been approved by the US Food and Drug Administration for use as a follow-up test after an abnormal Pap smear. The Hybrid Capture II HPV Test is performed by a health-care provider using a cervical swab. The test identifies the type of HPV infection and can differentiate between high-risk types (those associated with cervical cancer) and low-risk types.
HPV is the most common sexually transmitted disease in the United States, according to the American Social Health Association. While some types can cause genital warts, most HPV infections have no noticeable symptoms. Because some types of HPV infection can lead to cervical cancer, the US Centres for Disease Control and Prevention, along with many other health organisations, recommend that women receive routine Pap smears, which can identify abnormal changes in cervical cells.